Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 3
1959 3
1960 2
1961 4
1962 7
1963 5
1964 1
1965 1
1966 1
1968 3
1969 1
1970 1
1971 1
1972 2
1973 3
1975 2
1976 1
1981 1
1983 4
1985 1
1986 2
1987 1
1988 2
1992 1
1996 1
1998 2
2000 3
2001 2
2003 1
2004 8
2005 7
2006 3
2007 7
2008 16
2009 12
2010 9
2011 9
2012 8
2013 10
2014 10
2015 1
2016 9
2017 7
2018 7
2019 16
2020 9
2021 18
2022 18
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

228 results

Results by year

Filters applied: . Clear all
Page 1
Dendritic cell subsets in cancer immunity and tumor antigen sensing.
Del Prete A, Salvi V, Soriani A, Laffranchi M, Sozio F, Bosisio D, Sozzani S. Del Prete A, et al. Among authors: salvi v. Cell Mol Immunol. 2023 May;20(5):432-447. doi: 10.1038/s41423-023-00990-6. Epub 2023 Mar 22. Cell Mol Immunol. 2023. PMID: 36949244 Free PMC article. Review.
CCRL2 Expression by Specialized Lung Capillary Endothelial Cells Controls NK-cell Homing in Lung Cancer.
Sozio F, Schioppa T, Laffranchi M, Salvi V, Tamassia N, Bianchetto-Aguilera FM, Tiberio L, Bonecchi R, Bosisio D, Parmentier M, Bottazzi B, Leone R, Russo E, Bernardini G, Garofalo S, Limatola C, Gismondi A, Sciumè G, Mantovani A, Del Prete A, Sozzani S. Sozio F, et al. Among authors: salvi v. Cancer Immunol Res. 2023 Sep 1;11(9):1280-1295. doi: 10.1158/2326-6066.CIR-22-0951. Cancer Immunol Res. 2023. PMID: 37343073
Angiogenic and antiangiogenic chemokines.
Bosisio D, Salvi V, Gagliostro V, Sozzani S. Bosisio D, et al. Among authors: salvi v. Chem Immunol Allergy. 2014;99:89-104. doi: 10.1159/000353317. Epub 2013 Oct 17. Chem Immunol Allergy. 2014. PMID: 24217604 Review.
Cytokine Targeting by miRNAs in Autoimmune Diseases.
Salvi V, Gianello V, Tiberio L, Sozzani S, Bosisio D. Salvi V, et al. Front Immunol. 2019 Jan 29;10:15. doi: 10.3389/fimmu.2019.00015. eCollection 2019. Front Immunol. 2019. PMID: 30761124 Free PMC article. Review.
Extracellular miRNAs as activators of innate immune receptors.
Bosisio D, Gianello V, Salvi V, Sozzani S. Bosisio D, et al. Among authors: salvi v. Cancer Lett. 2019 Jun 28;452:59-65. doi: 10.1016/j.canlet.2019.03.021. Epub 2019 Mar 22. Cancer Lett. 2019. PMID: 30910591 Review.
The RIG-I agonist M8 triggers cell death and natural killer cell activation in human papillomavirus-associated cancer and potentiates cisplatin cytotoxicity.
Girone C, Calati F, Lo Cigno I, Salvi V, Tassinari V, Schioppa T, Borgogna C, Lospinoso Severini L, Hiscott J, Cerboni C, Soriani A, Bosisio D, Gariglio M. Girone C, et al. Among authors: salvi v. Cancer Immunol Immunother. 2023 Sep;72(9):3097-3110. doi: 10.1007/s00262-023-03483-7. Epub 2023 Jun 25. Cancer Immunol Immunother. 2023. PMID: 37356050 Free PMC article.
228 results